Valuation (28%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.35 | 18.54 |
| PEG Ratio (TTM) | 0.00 | 2.66 |
| P/S Ratio (TTM) | N/A | 4.01 |
| P/B Ratio (TTM) | 0.42 | 2.23 |
| P/FCF Ratio (TTM) | -0.52 | -1.42 |
| Price to 5YR AVG Earnings Ratio | N/A | 10.40 |
| Price to 5YR AVG FCF Ratio | N/A | -194.09 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -69.94% | 1.17% |
| ROE (TTM) | -110.41% | 11.85% |
| Net Profit Margin (TTM) | N/A | 20.53% |
| ROIC 5YR AVG | N/A | 15.10% |
Growth (13%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -307.89% | -1.29% | N/A |
| Revenue | 25.00% | N/A | N/A |
| Net Income | -19.80% | -1.29% | N/A |
| Cash Flow | 3.93% | -63.73% | N/A |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.01 | 3.22 |
| Quick Ratio (TTM) | 0.57 | 3.17 |
| D/E Ratio (TTM) | 0.36 | 2.65 |
| Interest Coverage (TTM) | -30.37 | 1.97 |
| Piotroski F-Score | 1 | 4 |
| Altman Z-Score | N/A | 1.13 |
| LTL to 5YR AVG FCF | N/A | -288.11 |
| Shares Outstanding Growth 5YR AVG | N/A | 0.97% |